Article

IRIDEX gets patents for Laserscope aesthetics

Mountain View, CA-IRIDEX Corp. has completed its acquisition of San Jose, CA-based Laserscope's aesthetics business.

Mountain View, CA-IRIDEX Corp. has completed its acquisition of San Jose, CA-based Laserscope's aesthetics business.

The $26 million cash and stock deal, announced Nov. 30, gives IRIDEX four patents, a license to an additional nine Laserscope patents, and a license under Palomar hair removal patents. IRIDEX also acquired between $7.3 million and $9.5 million in net assets under the transaction, including accounts receivable from Laserscope.

IRIDEX said the acquisition should more than double its 2006 revenues of $36 million in 2007, anticipating that revenue for the full year 2007 should be about $75 million.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.